Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The FDA accepted Monjuvi with Revlimid and Rituxan for follicular lymphoma, the identical mixture that introduced survivor Troy Anderson an enduring response.The U.S....
Dr. Monica Avila explains how most cancers remedies can set off early menopause, inflicting signs like sizzling flashes, temper modifications and irregular durations.Most...
